FDA Class II · Drug · July 22, 2026
Nystatin Cream USP recall — Padagis US LLC
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Official ID D-0677-2026 · Official record ↗
Padagis US recalls
Recall found. Padagis US is named in FDA Class II recall D-0677-2026 covering Nystatin Cream USP. Hazard: Subpotent Drug: Low out of specification assay results performed during long-term stability testing. Identifying details: Lot #: 205060, Exp 09/30/2027. Status: Ongoing.
Models with recalls
All Padagis US recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked September 7, 2026 at 6:00 AM UTC.